scientific program - World Allergy Organization
scientific program - World Allergy Organization
scientific program - World Allergy Organization
Create successful ePaper yourself
Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.
WAO Congress–XVIII ICACI Final Program<br />
POSTER SESSIONS<br />
THURSDAY, 11 SEPTEMBER - continued<br />
P-19-34 Impact of gastric digestion on allergenic molecules, epitopes<br />
and mimotopes: a pivotal role of antacids in the etiology of<br />
food allergy<br />
Untersmayr E1 , Schoell I1 , Walter F1 , Förster-Waldl E2 , Swoboda<br />
I3 , Jensen-Jarolim E1 , Riemer A1 , Scheiner O1 , Boltz-Nitulescu<br />
G1 , Spitzauer S3 1Dept. of Pathophysiology, University of Vienna, Vienna, Austria,<br />
2Clinics of Juvenile Medicine, University of Vienna, Vienna,<br />
Austria, 3Clin. Inst. for Medical and Chemical Laboratory<br />
Diagnostics, Vienna, Austria<br />
P-19-35 Production of an antibody fragment for studying a crossreactive<br />
IgE epitope on the major cherry allergen Pru av 1<br />
Wiche R1 , Schicktanz S1 , Scheurer S1 , Foetisch K1 , Hoffmann A1 ,<br />
Vieths S1 1Paul-Ehrlich-Institut, Langen, Germany<br />
Occupational Asthma and <strong>Allergy</strong><br />
P-20-1 Occupational asthma in Polish workers exposed to organic<br />
dust<br />
Milanowski JM1 , Szmygin-Milanowska KSM1 1Pulmonary Department, Medical University of Lublin, Lublin,<br />
Poland<br />
P-20-2 Occupational rhinitis in patients with occupational asthma<br />
Rosmaninho I1 , Torres da Costa J1 , Vaz M1 1H. S. Joao, Porto, Portugal<br />
P-20-3 Lysozyme-induced eosinophilic bronchitis without asthma in<br />
a baker<br />
Fernandez-Nieto MFN1 , Quirce SQ1 , Escudero CE1 , Sastre JS1 1Fundacion Jimenez Diaz, Madrid, Madrid, Spain<br />
P-20-4 Prevalence of latex allergy in a group of Venezuelan<br />
healthcare workers and cross-reactivity between latex and<br />
foods or inhalant allergens<br />
Asbati M1 , Puccio F1 , Capriles A2 , Di Prisco MC1 , Arteta M3 1 2 Instituto de Biomedicina/UCV, Caracas, Venezuela, Hospital<br />
San Juan de Dios/Centro Medico de Caracas, Caracas, Venezuela,<br />
3Universidad Central de Venezuela, Caracas, Venezuela<br />
P-20-5 Prevalence of respiratory symptoms in workers of a sealed<br />
office building in Rio de Janeiro, Brazil<br />
Rios JL1 , Boechat JL1 , Gioda A1 , França AT1 , Lapa e Silva JR1 ,<br />
Aquino Neto FR1 1Federal University of Rio de Janeiro, Rio de Janeiro, RJ, Brazil<br />
P-20-6 Occupational asthma: dolichol as a predictor of susceptibility<br />
Kuznecovs S1 , Joksta I2 , Kuznecova G1 1<strong>Allergy</strong> Unit, Public Health Research Laboratory, Riga, Latvia,<br />
2Latvian Medical Academy, Riga, Latvia<br />
Pharmacotherapy<br />
P-21-1 Mechanism of action and clinical application of<br />
polyoxidonium, an immunomodulator<br />
Pinegin BV1 , Khaitov RM1 , Nekrasov AV1 1Institute of Immunology, Moscow, Russian Federation<br />
P-21-2 Improved protection of a single dose of levocetirizine over<br />
desloratadine on the early allergic reaction in a nasal<br />
provocation test with allergen<br />
Spertini F1 , Deruaz C1 , Leimgruber A1 1Immunology and <strong>Allergy</strong>, Center Hospitalier Universitaire<br />
Vaudois, Lausanne, Switzerland<br />
93<br />
P-21-3 Efficacy of mizolastine in the treatment of chronic idiopathic<br />
urticaria<br />
Liu L1 , Dou D1 , Li M2 , Peng ZH3 , Guo ZP4 , Li FQ5 , Zhu XJ1 1Department of Dermatology, Peking University First Hospital,<br />
Beijing, China, 2Department of Dermatology, Zhong Shan Hospital,<br />
Fu Dan University, Shanghai, China, 3Department of Dermatology,<br />
The 2nd Hospital, Xian Jiaotong University, Xian, Shaanxi, China,<br />
4Department of Dermatology, Huaxi Hospital of Sichuan<br />
University, Chengdu, Sichuan, China, 5Department of<br />
Dermatology, The 2nd Hospital of Jilin University, Changchun,<br />
Jilin, China<br />
P-21-4 Effects of anti-allergic drugs on the activities of protein kinase<br />
C and protein phosphatase (IIA) using Pleckstrin as an<br />
endogenous substrate<br />
Imaoka T1 1Misuzugaoka-Higashi Hosp, Hiroshima, Hiroshima-Ken, Japan<br />
P-21-5 Vitamin A reduces lung inflammation with eosinophilia and<br />
neutrophilia in Sephadex-treated rats<br />
Torii A1 , Torii S2 , Miyake M1 , Morishita M3 , Ito K3 , Sakamoto T1 1Nagoya University Graduate School of Medicine, Nagoya, Japan,<br />
2The Faculty of Domestic Science of Aichi-Gakusen University,<br />
Okazaki, Japan, 3Aichi Children’s Health and Medical Center,<br />
Obu, Japan<br />
P-21-6 Influence of levocetirizine (LC) on lymphocytes<br />
Werfel T1 , Wittmann M1 , Kapp A1 1Dept Dermatology and Allergology, Hannover Medical University,<br />
Hannover, Germany<br />
P-21-7 Influences of mizolastine on rat paw edema induced by<br />
arachidonic acid<br />
Fu M1 , Zhang YG1 , Zhao XD1 , Liao WJ1 , Liu YF1 , Wang ZP1 1Xijing Hospital, Xi’an, Shaanxi, China<br />
P-21-8 Antihistaminic drugs and antileukotrienes: a way to decide about<br />
QOL in children with grass-pollen induced rhinitis<br />
Stencel-Gabriel K1 , Sadza K2 , Mertas T2 , Lukas A1 , Obuchowicz A1 1 2 3rd Clinic of Pediatrics, Bytom, Slaskie, Poland, Silesian Medical<br />
Academy, Zabrze, Slaskie, Poland<br />
P-21-9 Comparison of effectiveness between nebulized budesonide<br />
plus albuterol versus albuterol alone in children with<br />
moderate acute asthma<br />
Blandon MV1 , Rosas MA1 , Del Rio BE1 , Sienra JJ1 1Hospital Infantil de Mexico Federico Gomez, Mexico City,<br />
Mexico<br />
P-21-10 Role of leocetirizine, cetirizine and desloratidine in allergic<br />
bronchial asthma associated with rhinitis<br />
Pawar SS1 1Shriratna Intensive Care & Hospital, Karad, Maharashtra, India<br />
P-21-11 Comparing the safety consequences of newer antihistamines<br />
Hindmarch I1 1HPRU Medical Research Center, University of Surrey, Guildford,<br />
Surrey, UK<br />
P-21-12 Sustained efficacy of montelukast in seasonal allergic rhinitis<br />
(SAR) over 4 weeks of treatment<br />
van Adelsberg J1 , Menten J1 , Philip G1 , Reiss TF1 1Merck & Co., Inc., Rahway, NJ, USA<br />
P-21-13 Guideline-compliant treatment of allergic rhinitis in practice:<br />
an evaluation on the basis of 48,000 cases<br />
Mösges R 1 , Plenker A 2 , Goetze K 1 , Hilgenfeld A 3<br />
1 IMSIE-University at Cologne, Cologne, Germany, 2 Essex Pharma<br />
GmbH, Munich, Germany, 3 University of Aachen, Aachen,<br />
Germany<br />
THURSDAY